INTERNATIONAL PATENT: ZEALAND PHARMA A/S FILES APPLICATION FOR "DASIGLUCAGON FOR USE IN THE TREATMENT OF CONGENITAL HYPERINSULINISM"

GENEVA, March 24 -- ZEALAND PHARMA A/S (Sydmarken 112860 Soborg) filed a patent application (PCT/EP2024/075495) for "DASIGLUCAGON FOR USE IN THE TREATMENT OF CONGENITAL HYPERINSULINISM" on Sep 12, 2024. With publication no. WO/2025/056677, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): IVKOVIC, Jelena (c/o Zealand Pharma A/SSydmarken 112860 Soborg), BRAENDHOLT OLSEN, Minna (c/o Zealand Pharma A/SSydmarken 112860 Soborg), OWEN, Klara (c/o Zealand Pharma A/SSydmarken 112860 Soborg), BOGE, Eva (c/o Zealand Pharma A/SSydmark...